Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $4.65 Million - $6.68 Million
-78,865 Reduced 38.9%
123,857 $7.67 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $7.28 Million - $10.7 Million
91,723 Added 82.63%
202,722 $16.2 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $4.88 Million - $6.21 Million
-56,522 Reduced 33.74%
110,999 $11.7 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $16.5 Million - $20.1 Million
167,521 New
167,521 $18.1 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.